ArticleInvestigational new drugs2021

Phase 1a study of the CDK4/6 inhibitor, FCN-437c, in Chinese patients with HR + /HER2- advanced breast cancer.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.